These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 721814)

  • 1. Metabolism of tubercidin and formycin to their 3':5'-cyclic nucleotides in mammalian cells.
    Zimmerman TP; Wolberg G; Duncan GS
    J Biol Chem; 1978 Dec; 253(24):8792-7. PubMed ID: 721814
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of tubercidin and other adenosine analogs on Schistosoma mansoni schistosomules.
    Dovey HF; McKerrow JH; Wang CC
    Mol Biochem Parasitol; 1985 Aug; 16(2):185-98. PubMed ID: 3929087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubercidin metabolism in mouse L5178y cells in vivo and in vitro.
    Seibert G; Maidhof A; Zahn RK; Müller WE
    Gan; 1978 Dec; 69(6):739-47. PubMed ID: 750269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of adenosine kinase in the phosphorylation of formycin B in CHO cells.
    Mehta KD; Gupta RS
    Biochem Biophys Res Commun; 1985 Jul; 130(2):910-7. PubMed ID: 2992490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monophosphates of formycin B and allopurinol riboside. Interactions with leishmanial and mammalian succino-AMP synthetase and GMP reductase.
    Spector T; Jones TE; LaFon SW; Nelson DJ; Berens RL; Marr JJ
    Biochem Pharmacol; 1984 May; 33(10):1611-7. PubMed ID: 6732835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the conformations of cyclic nucleotides bound to the N-terminal core of the cyclic AMP receptor protein of Escherichia coli by 1H-NMR.
    Clore GM; Gronenborn AM
    FEBS Lett; 1982 Aug; 145(2):197-202. PubMed ID: 6290269
    [No Abstract]   [Full Text] [Related]  

  • 7. Nucleic acid related compounds. 51. Synthesis and biological properties of sugar-modified analogues of the nucleoside antibiotics tubercidin, toyocamycin, sangivamycin, and formycin.
    De Clercq E; Balzarini J; Madej D; Hansske F; Robins MJ
    J Med Chem; 1987 Mar; 30(3):481-6. PubMed ID: 3820218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of formycin B by Leishmania amastigotes in vitro. Comparative metabolism in infected and uninfected human macrophages.
    Berman JD; Rainey P; Santi DV
    J Exp Med; 1983 Jul; 158(1):252-7. PubMed ID: 6190980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of formycin B in Leishmania donovani.
    Nelson DJ; Lafon SW; Jones TE; Spector T; Berens RL; Marr JJ
    Biochem Biophys Res Commun; 1982 Sep; 108(1):349-54. PubMed ID: 7150292
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism and mechanism of action of formycin B in Leishmania.
    Rainey P; Santi DV
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):288-92. PubMed ID: 6572004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of formycin B as a general substrate for measuring facilitated nucleoside transport in mammalian cells.
    Plagemann PG; Woffendin C
    Biochim Biophys Acta; 1989 Jan; 1010(1):7-15. PubMed ID: 2909251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of pyrazolo[3,4,-d]pyrimidine nucleosides and nucleotides related to tubercidin, toyocamycin, and sangivamycin.
    Hecht SM; Frye RB; Werner D; Fukui T; Hawrelak SD
    Biochemistry; 1976 Mar; 15(5):1005-15. PubMed ID: 766833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemistry and biochemistry of C-nucleosides and C-arylglycosides.
    Hacksell U; Daves GD
    Prog Med Chem; 1985; 22():1-65. PubMed ID: 3915364
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of formycin nucleotides, intrinsic protein fluorescence, and fluorescein isothiocyanate-labeled enzymes for measurement of conformational states of Na+,K+-ATPase.
    Karlish SJ
    Methods Enzymol; 1988; 156():271-7. PubMed ID: 2835610
    [No Abstract]   [Full Text] [Related]  

  • 15. Formycin B-resistant mutants of Chinese hamster ovary cells: novel genetic and biochemical phenotype affecting adenosine kinase.
    Mehta KD; Gupta RS
    Mol Cell Biol; 1983 Aug; 3(8):1468-77. PubMed ID: 6312294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a new adenosine deaminase inhibitor, isocoformycin, on toxicity, antitumor activity and tissue distribution of formycin A and 9-beta-D-arabinofuranosyladenine.
    Hidaka T; Katayama K; Yamashita K; Yamashita T; Watanabe K; Shimazaki M; Ohno M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Mar; 33(3):303-9. PubMed ID: 7380742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic phosphates of formycin.
    Makabe O; Miyadera A; Kinoshita M; Umezawa S
    J Antibiot (Tokyo); 1978 May; 31(5):456-67. PubMed ID: 209007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single cell cloning of Leishmania parasites in purine-defined medium: isolation of drug-resistant variants.
    Iovannisci DM; Ullman B
    Adv Exp Med Biol; 1984; 165 Pt A():239-43. PubMed ID: 6720386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic trapping of intermediates of the scallop heavy meromyosin adenosine triphosphatase reaction revealed by formycin nucleotides.
    Jackson AP; Bagshaw CR
    Biochem J; 1988 Apr; 251(2):527-40. PubMed ID: 2969726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation.
    Berman JD
    J Parasitol; 1984 Aug; 70(4):561-2. PubMed ID: 6502359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.